Related Experiment Video
Updated: Mar 19, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Control and Eradication Strategies of Hepatitis B Virus
Chiaho Shih1, Shu-Fan Chou2, Ching-Chun Yang1
1Taiwan International Graduate Program (TIGP) in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Insights
New Hepatitis B virus (HBV) strategies aim to cure chronic infections by inhibiting viral entry, silencing cccDNA, and breaking immune tolerance, potentially improving cure rates.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) causes chronic hepatitis, leading to cirrhosis and hepatocellular carcinoma.
- Current HBV treatments (interferon, polymerase inhibitors) have limited efficacy and require lifelong therapy.
- Complete viral eradication remains a significant challenge in managing chronic HBV infections.
Purpose of the Study:
- To review recent advances in novel therapeutic strategies for chronic Hepatitis B virus infection.
- To explore new approaches beyond current treatment limitations.
- To discuss the potential of combination therapies for improving cure rates.
Main Methods:
- Literature review of recent scientific publications on HBV therapeutics.
- Analysis of emerging strategies targeting viral entry, cccDNA, and immune tolerance.
- Synthesis of findings on the efficacy of combined therapeutic approaches.
Main Results:
- Novel strategies include inhibiting HBV entry, destroying or silencing covalently closed circular DNA (cccDNA), and breaking immune tolerance.
- These new approaches offer potential for more effective HBV management.
- Combination therapies show promise for enhancing the cure rate of persistent HBV.
Conclusions:
- Emerging therapeutic strategies represent a significant advancement in the fight against chronic Hepatitis B.
- Targeting viral entry, cccDNA, and immune pathways offers new hope for a cure.
- Combining these novel strategies may significantly improve outcomes for patients with persistent HBV infection.
Abstract:
Hepatitis B virus (HBV) is a major human pathogen, and chronic hepatitis can lead to cirrhosis and malignant hepatocellular carcinoma. While HBV vaccine and treatment are available, it has remained a challenge to completely eradicate the virus from patients. Current therapy using either interferon or polymerase inhibitors cannot cure HBV with a high efficacy. Lifelong therapy is needed to suppress HBV in patients who achieve no seroconversion. Here, we review recent exciting advances of new strategies, including the inhibition of viral entry, the destruction or silencing of HBV covalently closed circular DNA (cccDNA), and breaking immune tolerance. Combinations of different therapeutic strategies could improve the cure rate of viral persistence in chronic hepatitis B.
More Related Videos
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Biological Methods for Microbial Control
Methods for Controlling Microbial Growth